Clinical trial Recruiting at 1 site Observational Ages 18 and up

Cerebral Small Vessel Disease Progression by Stroke Type

Official title: Biomarker-based Assessment of Cerebral Small Vessel Disease Progression After Lacunar and Territorial Stroke - a Prospective Cohort Study

Run by University Hospital Ulm · NCT07611136 · Data updated 2026-11-12

This study tests whether CSVD progresses differently if a patient has a concurrent ischemic stroke, using MRI and blood biomarkers in adults.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorUniversity Hospital Ulm
Academic / other
Locations1 site (Ulm, Baden-Wurttemberg)
StatusRecruiting
StartedMarch 26, 2026
Main results expectedApril 1, 2028
Study endsApril 1, 2028
Registry record updatedMay 28, 2026
Trial IDNCT07611136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with MRI-confirmed CSVD (white matter hyperintensities Fazekas 1–3) and the ability to provide informed consent in German.

Probably not a fit

Individuals without CSVD progression patterns or those lacking active stroke features may see limited direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study aiming to understand how cerebral small vessel disease (CSVD) evolves over time in relation to the type of ischemic stroke. Researchers will categorize participants based on MRI findings into CSVD without stroke, CSVD with lacunar stroke, or CSVD with territorial stroke and will measure blood biomarkers that may reflect CSVD course. Outcomes include neuropsychological and neurological function, quality of life, and stroke recurrence risk, with MRI to track CSVD changes. The study is conducted at University Hospital Ulm in Germany and focuses on adults with MRI-confirmed CSVD.

Why it matters

Potential benefit: If successful, findings could improve understanding of CSVD progression and help tailor monitoring and preventive strategies based on stroke type and biomarker patterns.

How similar studies have gone: Previous research has explored CSVD biomarkers and imaging, but this specific progression-by-stroke-type approach is relatively new and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Evidence of cerebral small vessel disease on brain MRI, defined as white matter hyperintensities (Fazekas grade 1-3)
* Assignment to one of the following study groups based on MRI findings:
* cerebral small vessel disease without evidence of an acute ischemic stroke
* cerebral small vessel disease with acute lacunar ischemic stroke
* cerebral small vessel disease with acute territorial ischemic stroke
* Ability to provide written informed consent
* Sufficient German language skills to understand study procedures and assessments

Exclusion Criteria:

* Alternative plausible causes of white matter hyperintensities other than cerebral small vessel disease (e.g. inflammatory central nervous system disorders, leukodystrophies, brain tumors)
* Known neurodegenerative diseases (e.g. Parkinson's disease, Alzheimer's disease, other dementias)
* Acute or recent traumatic brain injury
* Contraindications to magnetic resonance imaging
* Pregnancy or breastfeeding
* Life expectancy of less than one year
* Inability to comply with study procedures or follow-up visits

Where it's running

  • University Hospital Ulm, Department of Neurology, Germany
    Ulm, Baden-Wurttemberg, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.